Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Echinomycin: a bifunctional intercalating antibiotic.

× No keyword cloud information.

71 in total

1. DNA polyintercalating drugs: DNA binding of diacridine derivatives.

Authors: J B Le Pecq; M Le Bret; J Barbet; B Roques
Journal: Proc Natl Acad Sci U S A Date: 1975-08 Impact factor: 11.205

2. Stereochemical aspects of the interaction between steroidal diamines and DNA.

Authors: M J Waring; S M Henley
Journal: Nucleic Acids Res Date: 1975-04 Impact factor: 16.971

3. Energetics of echinomycin binding to DNA.

Authors: Fenfei Leng; Jonathan B Chaires; Michael J Waring
Journal: Nucleic Acids Res Date: 2003-11-01 Impact factor: 16.971

4. The 2-amino group of guanine is absolutely required for specific binding of the anti-cancer antibiotic echinomycin to DNA.

Authors: C Marchand; C Bailly; M J McLean; S E Moroney; M J Waring
Journal: Nucleic Acids Res Date: 1992-11-11 Impact factor: 16.971

5. Interaction of echinomycin with An.Tn. and (AT)n regions flanking its CG binding site.

Authors: K Waterloh; K R Fox
Journal: Nucleic Acids Res Date: 1991-12-25 Impact factor: 16.971

6. A new bisintercalating anthracycline with picomolar DNA binding affinity.

Authors: José Portugal; Derek J Cashman; John O Trent; Neus Ferrer-Miralles; Teresa Przewloka; Izabela Fokt; Waldemar Priebe; Jonathan B Chaires
Journal: J Med Chem Date: 2005-12-29 Impact factor: 7.446

7. Echinomycin and distamycin induce rotation of nucleosome core DNA.

Authors: C M Low; H R Drew; M J Waring
Journal: Nucleic Acids Res Date: 1986-09-11 Impact factor: 16.971

8. Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia.

Authors: W R Waud; S D Harrison; K S Gilbert; W R Laster; D P Griswold
Journal: Cancer Chemother Pharmacol Date: 1991 Impact factor: 3.333

9. Localized chemical reactivity in DNA associated with the sequence-specific bisintercalation of echinomycin.

Authors: C Bailly; D Gentle; F Hamy; M Purcell; M J Waring
Journal: Biochem J Date: 1994-05-15 Impact factor: 3.857

10. Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641.

Authors: R L Schilsky; D Faraggi; A Korzun; N Vogelzang; J Ellerton; W Wood; I C Henderson
Journal: Invest New Drugs Date: 1991-08 Impact factor: 3.850